OBJECTIVE: To learn if treatment of recurrent nonmelanoma skin cancer (NMSC) varied in different practice settings. DESIGN: Prospective cohort study of consecutive patients with recurrent NMSC. SETTING: A university-based dermatology practice and the dermatology clinic at the affiliated Veterans Affairs Medical Center (VAMC). Conventional therapies for NMSC were available at both sites. Patients All 191 patients diagnosed as having recurrent NMSC in 1999 and 2000 were included in the study. Data were collected from medical record review and surveys mailed to patients. Main Outcome Measure Performance of Mohs micrographic surgery (Mohs). RESULTS: Patients at the VAMC were older, less educated, poorer, and had more comorbid illnesses, but their tumors were similar to those of patients at the university-based practice. Treatment choices differed at the 2 sites: the proportions of tumors treated in the VAMC and university sites were 60% and 14%, respectively, for excisional surgery; and 24% and 61%, respectively, for Mohs (P < .001). In multivariate analyses adjusting for patient, tumor, and physician features that may have affected treatment choice, tumors treated at the university-based site remained significantly more likely to be treated with Mohs (odds ratio, 8.68 [95% confidence interval, 3.66-20.55]; P < .001). CONCLUSIONS: Substantial variation existed in the treatment of recurrent NMSC in different practice settings. This variation was not explained by measured clinical characteristics of the patients or the tumors.
OBJECTIVE: To learn if treatment of recurrent nonmelanoma skin cancer (NMSC) varied in different practice settings. DESIGN: Prospective cohort study of consecutive patients with recurrent NMSC. SETTING: A university-based dermatology practice and the dermatology clinic at the affiliated Veterans Affairs Medical Center (VAMC). Conventional therapies for NMSC were available at both sites. Patients All 191 patients diagnosed as having recurrent NMSC in 1999 and 2000 were included in the study. Data were collected from medical record review and surveys mailed to patients. Main Outcome Measure Performance of Mohs micrographic surgery (Mohs). RESULTS:Patients at the VAMC were older, less educated, poorer, and had more comorbid illnesses, but their tumors were similar to those of patients at the university-based practice. Treatment choices differed at the 2 sites: the proportions of tumors treated in the VAMC and university sites were 60% and 14%, respectively, for excisional surgery; and 24% and 61%, respectively, for Mohs (P < .001). In multivariate analyses adjusting for patient, tumor, and physician features that may have affected treatment choice, tumors treated at the university-based site remained significantly more likely to be treated with Mohs (odds ratio, 8.68 [95% confidence interval, 3.66-20.55]; P < .001). CONCLUSIONS: Substantial variation existed in the treatment of recurrent NMSC in different practice settings. This variation was not explained by measured clinical characteristics of the patients or the tumors.
Authors: N W J Smeets; D I M Kuijpers; P Nelemans; J U Ostertag; M E J M Verhaegh; G A M Krekels; H A M Neumann Journal: Br J Dermatol Date: 2004-07 Impact factor: 9.302
Authors: Mary-Margaret Chren; Anju P Sahay; Laura P Sands; Leah Maddock; Karla Lindquist; Daniel Bertenthal; Peter Bacchetti Journal: Med Care Date: 2004-10 Impact factor: 2.983
Authors: Nicole W J Smeets; Gertruud A M Krekels; Judith U Ostertag; Brigitte A B Essers; Carmen D Dirksen; Fred H M Nieman; H A Martino Neumann Journal: Lancet Date: 2004 Nov 13-19 Impact factor: 79.321